Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · June 25, 2023

Real-World Driving Data as a Biomarker of Symptom Severity and Dopaminergic Treatment Effects in People With Parkinson's Disease

Movement Disorders Clinical Practice


Additional Info

Movement Disorders Clinical Practice
Real-world driving data indexes dopaminergic treatment effects in Parkinson's Disease
Mov Disord Clin Pract 2023 Jun 02;[EPub Ahead of Print], JH Chang, D Bhatti, M Rizzo, EY Uc, J Bertoni, J Merickel

Further Reading